Article
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
PloS one - 2 Jul 2008
Patel Alpa V, Cheng Iona, Canzian Federico, Le Marchand Loïc, Thun Michael J, Berg Christine D, Buring Julie, Calle Eugenia E, Chanock Stephen, Clavel-Chapelon Francoise, Cox David G, Dorronsoro Miren, Dossus Laure, Haiman Christopher A, Hankinson Susan E, Henderson Brian E, Hoover Robert, Hunter David J, Kaaks Rudolf, Kolonel Laurence N, Kraft Peter, Linseisen Jakob, Lund Eiliv, Manjer Jonas, McCarty Catherine, Peeters Petra H M, Pike Malcolm C, Pollak Michael, Riboli Elio, Stram Daniel O, Tjonneland Anne, Travis Ruth C, Trichopoulos Dimitrios, Tumino Rosario, Yeager Meredith, Ziegler Regina G, Feigelson Heather Spencer
Abstract excerpt
IGF-1 has been shown to promote proliferation of normal epithelial breast cells, and the IGF pathway has also been linked to mammary carcinogenesis in animal models. We comprehensively examined the association between common genetic variation in the IGF1, IGFBP1, and IGFBP3 genes in relation to c...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
